RxE2
RxE2 is revolutionizing clinical trials by integrating community pharmacists into the process, powered by advanced technology. The company provides patient recruitment, dispensing, counseling, and operational services to pharmaceutical and biotech industries. Their innovative approach addresses long-standing issues in clinical trials such as time, cost, and quality by leveraging pharmacists' access to patients and community relationships. RxE2's platform enhances drug development efficiency and patient access, making clinical trials a viable healthcare option for everyone, everywhere. The company also acquired Habitu Ltd. to form the first AI-driven, pharmacist-led clinical trial platform, further advancing their technology and market position.
RxE2
RxE2 is revolutionizing clinical trials by integrating community pharmacists into the process, powered by advanced technology. The company provides patient recruitment, dispensing, counseling, and operational services to pharmaceutical and biotech industries. Their innovative approach addresses long-standing issues in clinical trials such as time, cost, and quality by leveraging pharmacists' access to patients and community relationships. RxE2's platform enhances drug development efficiency and patient access, making clinical trials a viable healthcare option for everyone, everywhere. The company also acquired Habitu Ltd. to form the first AI-driven, pharmacist-led clinical trial platform, further advancing their technology and market position.